Type 1 diabetes: treatment [sounds like]
299 results
1 - 100
Type 1 diabetes: treatment - Essentials
- Investigating high-blood-glucose homeostasis and variation of blood glucose concentrations
- Targets for glycaemic control
- Multiple injection regime and travel across time zones
- References
- Assessing appropriate insulin dose
- Principles of insulin administration
- Utilization of self-monitoring of blood glucose
- Injection of insulin
- Dietary principles
- Physical exercise and insulin treatment
- Hypoglycaemia
- Hyperglycaemia
Hormone replacement therapy for women with type 1 diabetes mellitus: Cochrane systematic review- Metformin in the treatment of type II diabetes
- Newly diagnosed type 1 diabetes in a child
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents New
Hydrolyzed infant formula does not reduce the risk of type 1 diabetes- Oral antidiabetic drugs and GLP-1 analogues
- Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus: Cochrane systematic review
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus: Cochrane systematic review
- Enhanced glucose control for preventing and treating diabetic neuropathy: Cochrane systematic review
- Glimepiride in the treatment of type 2 diabetes
- Gestational diabetes mellitus (GDM)
- Group based training for self-management strategies in people with type 2 diabetes mellitus
- Treatment and follow-up in type 2 diabetes
- (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus New
- Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus Edited (no change to conclusions)
- Type 1 diabetes in fair to good control not associated with reduced school performance in children
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus: Cochrane systematic review
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus New
- Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
- Dietary advice and exercise for type 2 diabetes mellitus
- Different insulin types and regimens for pregnant women with pre-existing diabetes: Cochrane systematic review
- Exercise for pregnant women with pre-existing diabetes for improving maternal and fetal outcomes: Cochrane systematic review
- Risk of severe hypoglycemia similar between different insulin formulations
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia: Cochrane systematic review
- Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
- Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus: Cochrane systematic review
- Continuous subcutaneous insulin infusion for type 1 diabetes
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Risk test for type 2 diabetes
- Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance: Cochrane systematic review
- Individualizing target goals and treatment in patients with type 2 diabetes
- Rosiglitazone for type 2 diabetes mellitus
- Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus Edited (no change to conclusions)
- Linagliptin and glimepiride equally effective for adults with type 2 diabetes
- Hyperbaric O2 therapy may improve diabetic foot ulcers
- Dietary advice for the prevention of type 2 diabetes mellitus in adults: Cochrane systematic review
- A child or adolescent with type 1 diabetes in primary health care
- No benefit to screening with CT angiography for asymptomatic CAD in adults with diabetes
- Exercise and diet for preventing type 2 diabetes mellitus
- Linagliptin and glimepiride equally effective for adults with type 2 diabetes: POEM amended to include Canadian pricing
- Metformin monotherapy for adults with type 2 diabetes mellitus New
- NICE guidelines for diabetes mellitus, type 2
- Cinnamon for diabetes mellitus: Cochrane systematic review
- Severe hypoglycemic episodes raise risk of dementia in adults with T2DM
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
- Diabetes: definition, differential diagnosis and classification
- Mediterranean diet delays treatment of type 2 diabetes
- Blood pressure control for diabetic retinopathy: Cochrane systematic review
- Intensive control of blood sugar (HbA1c < 7.0%) in DM2 may be harmful (ACCORD)
- Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
- Metformin minimally beneficial, if at all, when added to insulin in overweight adolescents with T1DM
- Uncertain if tight control reduces long-term mortality in patients with T1DM
- Metformin should be initial therapy for adults with type 2 DM
- Fenofibrate decreases amputation in patients with type 2 DM (FIELD)
- Diabetic kidney disease (diabetic nephropathy)
- J-shaped survival curve for glycemic control in patients with type 2 DM
- Similar long-term morbidity and mortality with human insulin and analogue insulins
- Insulin therapy in type 2 diabetes
- Liraglutide for weight loss among patients with type 2 diabetes
- Home glucose monitoring offers no benefit to patients not using insulin
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
- Altered dietary salt intake for preventing and treating diabetic kidney disease: Cochrane systematic review
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
- GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease